UPDATE: Protagonist Therapeutics (PTGX) PT Raised to $93 at Piper Sandler on PN-943 Increasing Likelihood of Success
Tweet Send to a Friend
(Updated - July 30, 2021 10:13 AM EDT)
Piper Sandler analyst Yasmeen Rahimi raised the price target on Protagonist ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Yasmeen Rahimi raised the price target on Protagonist ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
